2014
DOI: 10.1148/radiol.14132914
|View full text |Cite
|
Sign up to set email alerts
|

Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy

Abstract: Partial regression of tumor-vessel contact indicates suitability for surgical exploration, irrespective of the degree of decrease in tumor size or the degree of residual vascular involvement.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
70
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 120 publications
(79 citation statements)
references
References 20 publications
4
70
0
1
Order By: Relevance
“…The search yielded 649 studies of which 15 published between 2009 and 2017 were included in the final analysis (Fig. ) . These 15 studies included 995 patients with BRPC ( n = 683) and locally advanced ( n = 312) PDAC.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The search yielded 649 studies of which 15 published between 2009 and 2017 were included in the final analysis (Fig. ) . These 15 studies included 995 patients with BRPC ( n = 683) and locally advanced ( n = 312) PDAC.…”
Section: Resultsmentioning
confidence: 99%
“…These 15 studies included 995 patients with BRPC ( n = 683) and locally advanced ( n = 312) PDAC. All the studies originated from single institutions in the USA ( n = 9), France ( n = 3), Korea ( n = 2) and Spain ( n = 1) . Only one study was prospective in design, with the rest being retrospective (cohort or case controlled) studies.…”
Section: Resultsmentioning
confidence: 99%
“…The establishment in the method of evaluation of chemo‐responsiveness before neoadjuvant therapy to give individualized treatment is an urgent issue for BRPC patients. The difficulty in using CT to reassess local regional tumor extension after completion of preoperative neoadjuvant therapy in several studies and tumor size evaluation using RECIST on CT imaging was that it revealed no significant association with treatment response or R0 resection. We found similar results in the present study.…”
Section: Discussionmentioning
confidence: 99%
“…A 2013 study showed diminished performance of CT scan accuracy predicting R0 resectability or unresectability after preoperative therapy with gemcitabine or 5-Flourouracil when compared to patients treated with first-line surgery (58% vs 83% and 52 vs 88%, respectively) (32). A study from the same year, despite being carried out in a small number of selected patients, concluded that neither changes in tumor CT attenuation nor changes in vascular involvement contributed to the prediction of resectability, and its findings were partially confirmed by a later study performed on a larger cohort, showing that only a partial decrease in tumor-vessel contact or even small decrease in tumor size was associated with R0 resection, in contrast to changes in tumor attenuation (33,34).…”
Section: Radiographic Responsementioning
confidence: 99%